ALRM
Alarm.com Holdings, Inc.
ALRM's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over ALRM overall, supported by stronger modeled upside and stronger fundamentals.
ALRM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
ALRM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
ALRM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 22x | $66.42 | — |
| Cheap | 24x | $53.89 | -19% |
| Current | 29x | $66.42 | — |
| Fair | 45x | $103 | +55% |
| Expensive | 62x | $140 | +112% |
Historical ranges are pointers, not guarantees.
ALRM's PE is in its cheap range at 29x. If earnings grow as analysts expect, today's price would be 22x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over ALRM in the historical PE scenario, which offers more potential upside but is not a forecast.
ALRM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
ALRM has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
ALRM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.99 | +32% |
| Q3 2026 | $2.27 | -3.8% |
| Q2 2026 | $2.26 | -5% |
| Q1 2026 | $2.41 | +1.7% |
| Q4 2025 | $2.46 | +7.4% |
| Q3 2025 | $2.36 | +2.2% |
| Q2 2025 | $2.38 | +18% |
| Q1 2025 | $2.37 | +40% |
| Q4 2024 | $2.29 | +50% |
ALRM earned $2.27 per share over the past year, down 3.8% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over ALRM on earnings, with more consistent year-over-year improvement.
ALRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $279.4M | +9% |
| Q2 2026 | $277.7M | +9.2% |
| Q1 2026 | $265.2M | +11% |
| Q4 2025 | $261.7M | +8% |
| Q3 2025 | $256.4M | +6.6% |
| Q2 2025 | $254.3M | +8.8% |
| Q1 2025 | $238.8M | +7% |
| Q4 2024 | $242.2M | +7.1% |
ALRM's revenue has grown year over year every quarter since late 2020: $279M last quarter, up 9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | +1.3 points |
| Q2 2026 | 12% | -0.9 points |
| Q1 2026 | 12% | -0.5 points |
| Q4 2025 | 13% | +0.6 points |
| Q3 2025 | 14% | +0.6 points |
| Q2 2025 | 13% | +1.6 points |
| Q1 2025 | 12% | +4 points |
| Q4 2024 | 13% | +1.4 points |
ALRM's operating margin was 16% last quarter, up 1.3 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over ALRM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over ALRM on profitability, with a higher operating margin.
ALRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $69.5M | +5.5% |
| Q2 2026 | $37M | +104% |
| Q1 2026 | $49.7M | +177% |
| Q4 2025 | $35.1M | -35% |
| Q3 2025 | $65.9M | -12% |
| Q2 2025 | $18.2M | -13% |
| Q1 2025 | $17.9M | -62% |
| Q4 2024 | $54M | +43% |
ALRM generated $191M in free cash flow over the past year, up 23% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over ALRM on cash flow, with more consistent year-over-year improvement.
ALRM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +58K shares |
| 1 year | -4.2% | -2.5M shares |
| 3 years | +2.2% | +1.2M shares |
| 5 years | +8% | +4.1M shares |
| Available history | +11% | +5.7M shares |
ALRM has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.4M |
| Q2 2026 | $25M |
| Q1 2026 | $20M |
| Q4 2025 | $19.1M |
| Q3 2025 | $12.3M |
| Q2 2025 | $5.1M |
| Q1 2025 | $5.1M |
| Q4 2024 | — |
ALRM spent $78M buying back its own shares over the past year, about three times what it spent the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
ALRM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.0x | Net Cash |
| Q2 2026 | -2.8x | Net Cash |
| Q1 2026 | -3.0x | Net Cash |
| Q4 2025 | -5.8x | Net Cash |
| Q3 2025 | -6.7x | Net Cash |
| Q2 2025 | -6.6x | Net Cash |
| Q1 2025 | -8.0x | Net Cash |
| Q4 2024 | -8.9x | Net Cash |
ALRM has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ALRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.2 | Overbought |
| Stochastic | 80.3 | Overbought |
ALRM's weekly RSI is 74 (overbought) and its Stochastic is 80 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
ALRM PE vs Technology Sector
| Metric | ALRM | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 28x | 5% above |
| PE % | 31 | 35 | 4 pts below |
ALRM is trading at 29x earnings, in line with the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over ALRM on valuation relative to its sector.
ALRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $60.2 | 10% above |
| 20 week MA | $56.8 | 17% above |
| 50 week MA | $51.1 | 30% above |
| 100 week MA | $53.5 | 24% above |
| 200 week MA | $56.2 | 18% above |
ALRM has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
ALRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.8 | $98.9 | +131% |
| 2021 | $98.9 | $82.8 | -16% |
| 2022 | $82.8 | $49.0 | -41% |
| 2023 | $49.0 | $64.6 | +32% |
| 2024 | $64.6 | $62.1 | -3.9% |
| 2025 | $62.1 | $51.8 | -17% |
| 2026 YTD | $51.8 | $66.4 | +28% |
ALRM has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.